Glucan-based vaccines
CA 2830619 A1 · Owner: Polonelli, Luciano · Inventors: Cassone, Antonio; Polonelli, Luciano
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Anti-glucan antibodies have been found to be protective against systemic fungal infection with , C.albicans, but the protective efficacy can be inhibited by blocking antibodies. The invention , provides an immunogenic composition comprising a glucan and a pharmaceutically acceptable , carrier, characterised in that when administered to a mammalian recipient the composition , elicits protective anti-glucan antibodies but does not elicit antibodies which inhibit the protective , efficacy of the anti-glucan antibodies. The glucan may be presented on the surface of a protease-treated, microbial cell or may be presented as a protein-glucan conjugate. The glucan may be , substituted by a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 15, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 15, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 15, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.